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ABSTRACT 
 
Perivascular macrophages are believed to have a significant role in 
inflammation in the central nervous system (CNS). They express a number of 
different receptors which point towards functions in both innate immunity, through 
pattern-associated antigen recognition, phagocytosis and cytokine responsiveness, 
and acquired immunity, through antigen presentation and co-stimulation. We are 
interested in the receptors which are differentially expressed by perivascular 
macrophages and microglia in both the normal CNS as well as in neuroinflammation 
and neurodegeneration. In this paper we report the use of a well characterized 
monoclonal antibody 5D3 to localize the expression of the mannose receptor to 
perivascular macrophages in both the normal CNS and in various models of brain 
pathology. Mannose receptor expression was limited to perivascular, meningeal and 
choroid plexus macrophages in normal, inflamed, injured and diseased CNS. In 
particular activated microglia and invading haematogenous leucocytes were mannose 
receptor negative while expressing the F4/80 antigen, macrosialin (CD68), FcRII 
(CD32), scavenger receptor (CD204) and CR3 (CD11b/CD18). Since the 
perivascular macrophages expressing the mannose receptor are known to be the only 
constitutively phagocytic cells in the normal CNS, we injected clodronate-loaded 
liposomes intracerebroventricularly in control mice to deplete these cells. In these 
mice there was no detectable mannose receptor expression in perivascular spaces 
after immunocytochemistry with the 5D3 monoclonal antibody. This underlines the 
value of the monoclonal antibody 5D3 as a tool to selectively study murine 
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perivascular macrophages. Mannose receptor expression by macrophages located at 
blood-brain (perivascular), brain-CSF (meningeal) and CSF-blood (choroid plexus) 
interfaces supports a functional role of these cells in responding to external stimuli 
such as infection. 
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INTRODUCTION 
 
Cerebral perivascular macrophages (PVMs) are interesting cells by virtue of their 
location at the blood-brain barrier (BBB). They are situated between the endothelial 
basement membrane and the glia limitans (Graeber et al., 1992). They are the only 
cells in the brain parenchyma which display constitutive phagocytic potential (Kida et 
al., 1993) and immunophenotypical markers of activation such as MHC class II, B7, 
CD40 and FcR (Williams et al., 2001). They are the first cells to respond to 
inflammation within the brain in various experimental settings such as EAE (Hickey 
et al., 1987), neuronal damage (Streit et al., 1989) and intracerebroventricular 
injection of IFN-γ or TNF-α (Lassmann et al., 1991). They also readily respond to 
peripheral immune activation after systemic lipopolysaccharide administration 
(Breder et al., 1994; Elmquist et al., 1997; Herkenham et al., 1998; Schiltz and 
Sawchenko, 2002). Moreover, they have been shown to be capable of effective 
antigen presentation (Ford et al., 1995; Hickey and Kimura, 1988). Thus they are 
ideally situated to respond to pro-inflammatory stimuli arising from both within the 
brain and from the periphery.   
 PVMs have mostly been studied in the rat because of the availability 
of the monoclonal antibody ED2, which recognizes CD163. CD163 is a member of 
the scavenger receptor Type B family and has several functions: haemoglobin 
scavenging (Kristiansen et al., 2001), cell adhesion (Barbe et al., 1996; Wenzel et al., 
1996), and perhaps an anti-inflammatory role (Hogger and Sorg, 2001). In the rat 
central nervous system (CNS), ED2 selectively labels perivascular, meningeal and 
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choroid plexus macrophages in both normal and inflamed CNS (Dijkstra et al., 1985). 
Recently a monoclonal antibody (EDHu-1) recognizing human CD163 and thus 
perivascular macrophages, has become available (Kristiansen et al., 2001). Studying 
PVM biology in the mouse has been hampered by the lack of availability of such a 
selective marker. Although murine CD163 has been cloned (Schaer et al., 2001), an 
anti-mouse CD163 antibody is still lacking. The monoclonal antibody 2F8 recognizes 
the murine scavenger receptor A which is limited to PVMs in the normal brain (Mato 
et al., 1996). However this receptor is expressed by microglia during different forms 
of injury (Bell et al., 1994), making it hard to study PVMs selectively in pathological 
conditions. 
 We have systematically studied a number of monoclonal antibodies to mouse 
macrophage antigens in order to further characterize the murine PVM’s expression 
profile and thus gain more insight into its function. One of these antibodies is the 
monoclonal antibody 5D3 which recognizes the mannose receptor (MR). The MR is a 
Type I transmembrane C-type lectin which best recognizes branched mannose-
containing carbohydrate structures on both microbial and host proteins (Linehan et 
al., 2000a). Its extracellular portion includes 8 carbohydrate recognition domains 
(CRDs) and an N-terminal cysteine-rich domain (CR), which display separate lectin 
activities. It is expressed by tissue macrophages, hepatic and lymphatic endothelium, 
glomerular mesangial cells and “perivascular microglia” in the normal brain (Linehan 
et al., 1999). Its functions include receptor-mediated endocytosis and phagocytosis, 
modulation of microbicidal potential, cell adhesion, stimulation of cytokine secretion, 
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targeting of antigen to MHC Class II pathway and antigen trafficking in lymphoid 
organs (Apostolopoulos and McKenzie, 2001). 
 
We have investigated MR expression in the normal CNS as well as in several models 
of pathology. We were especially interested to determine whether the MR is still 
selectively expressed on PVMs in these models. Our study clearly shows that the MR 
is exclusively expressed by perivascular macrophages (PVMs), meningeal 
macrophages (MMs) and choroid plexus macrophages (CPMs) in the normal CNS, as 
is the case with ED2 in the rat. Moreover its expression remains limited to these 
macrophages even under conditions of acute and chronic neurodegeneration and 
following an inflammatory challenge. Mannose receptor expression by macrophages 
situated at blood-brain (perivascular), brain-CSF (meningeal) and CSF-blood 
(choroid plexus) interfaces supports a functional role of these cells in responding to 
external stimuli such as infection.  
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MATERIALS AND METHODS 
 
Animals 
Female C57BL/6J mice, obtained from Harlan-Orlac (Bicester, UK), were 4-6 weeks 
old on arrival and were group-housed under a 12h light:12h dark schedule. Mice were 
maintained under controlled environmental conditions with pelleted food and water 
ad libitum. The experiments were carried out under Home Office Licence and in 
accordance with the Animals (Scientific Procedures) Act, 1986. All efforts were 
made to minimize both the suffering and the number of animals used. 
 
Preparation of multilamellar liposomes 
Multilamellar mannosylated liposomes were prepared as described before (van 
Rooijen and Sanders, 1994). Briefly, 178mg phosphatidylcholine (Lipoid GmbH, 
Ludwigshafen, Germany) and 27mg cholesterol (Sigma Chemicals) were dissolved in 
8ml chloroform which was added to 9.25mg p-amino-phenyl-α-D-mannopyranoside 
(Sigma Chemicals) dissolved in 5ml methanol in a 500ml round-bottom flask. This 
was dried in vacuo on a rotary evaporator to form a film. The molar ratio of 
phosphatidylcholine / cholesterol / mannoside was 7:2:1. The lipid film was dispersed 
in 10ml of phosphate buffered saline (PBS, 0.15M NaCl in 10mM phosphate buffer, 
pH 7.4) for the preparation of PBS-containing mannosylated liposomes. To enclose 
the clodronate, 2.5g (a gift of Roche Diagnostics, Mannheim, Germany) was 
dissolved in 10ml milliQ (set at pH 7.3 with NaOH) in which the lipid film was 
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dispersed and the preparations were kept for 2h at room temperature, sonicated for 
3min, washed and resuspended in 10ml of PBS. The size of the liposomes ranged 
from 0.2 to 3µm.  
 
Intraventricular liposome infusion 
Mice were deeply anaesthetized with isoflurane in O2 and mounted on a stereotaxic 
frame. In a first experiment the published protocol for PVM depletion in the rat 
(Polfliet et al., 2001a) was adapted to the mouse on a per brain weight basis. Thus 8µl 
of clodronate or PBS-containing mannosylated liposomes were infused into the 4th 
ventricle of 4 mice over 25min using a Hamilton syringe fitted with a 27G needle. 
This preliminary study resulted in suboptimal depletion despite correct localization of 
the injection being confirmed by serial sectioning of the brain around the injection 
site. The protocol was therefore modified. The liposome dose was doubled and 
injections were made rostrally in the lateral ventricles in order to facilitate access of 
the liposomes to the whole brain parenchyma. Thus, in a second experiment, 8µl of 
clodronate or PBS-containing mannosylated liposomes were infused into each lateral 
ventricle of 3 mice slowly over 12.5min using a pulled glass capillary (co-ordinates: -
0.22mm, lateral 1mm and depth 2mm). On each side, the capillary was left in situ for 
2.5min, withdrawn partially and left for a further 2.5min before being removed 
completely, to avoid reflux of liposomes along the injection tract. The operated mice 
were sacrificed 5 days later. 
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Controls 
Three naïve mice were used as controls for the brain pathology models, except in the 
case of the Wallerian degeneration model, where the contralateral left unoperated 
optic nerve was used as control.  
 
Brain pathology models 
Experiments were carried out as described previously (Andersson et al., 1991; 
Andersson et al., 1992; Betmouni et al., 1996; Lawson et al., 1994). All surgery was 
performed on anaesthetised animals with Avertin (2,2,2-tribromoethanol in tertiary 
amyl alcohol) at a dose of 0.1ml/5g body weight. With the exception of the Wallerian 
degeneration model, all the mice were injected stereotaxically in the dorsal 
hippocampus (co-ordinates: bregma –1.94mm, lateral 1.5mm and depth -1.37mm). A 
pulled glass micropipette was used for lipopolysaccharide (LPS) and kainic acid 
(KA) injection, and a Hamilton syringe with a blunt 26S needle for the ME7 prion 
brain homogenate injection. For all animal models, the mice were allowed to recover 
under a warm lamp and then housed in IVC racks (Techniplast UK, Kettering, UK) 
following surgery. All the mice were sacrificed by deep anaesthesia with 20% sodium 
pentobarbital (Sagatal, Rhone Merieux Ltd., Harlow, Essex, UK). 
 
Acute inflammatory model. Three animals were injected with 1µl of LPS (2µg/µl) 
(Salmonella abortus equi, Lot No 69F4003, Sigma Chemicals, Poole, UK) in the 
right dorsal hippocampus and sacrificed 24h later (Andersson et al., 1992). 
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Acute neurodegeneration model. Three mice were injected with 1µl of KA (1nM) 
(Sigma Chemicals, Poole, UK) in the right dorsal hippocampus and sacrificed three 
days later (Andersson et al., 1991). 
 
Chronic neurodegeneration model. Mice were bilaterally injected in the dorsal 
hippocampus with 1µl of ME7 prion brain homogenate using a Hamilton syringe 
fitted with a blunt 26S needle (Betmouni et al., 1996). The syringe was left in situ for 
an additional 1min to prevent reflux along the injection tract. The ME7 prion brain 
homogenate was derived from the brains of C57BL/6J mice at 22 weeks old post-
inoculation showing clinical signs of disease (10% w/v in sterile PBS). Mice were 
sacrificed at the terminal stage of the disease (21 weeks, n=3). 
 
Wallerian degeneration model. The mouse right optic nerve was crushed 
intraorbitally under an operating microscope with jeweller forceps for 10sec (ONC) 
(Lawson et al., 1994). Mice were killed at 7 and 28 days after the injury (n=3 at each 
time point). 
 
Tissue processing and immunohistochemistry 
Animals were transcardially perfused with 0.9% w/v heparinized saline under 
terminal anaesthesia with 20% sodium pentobarbital. Brain tissue was rapidly 
dissected, frozen in Tissue-Tek OCT embedding compound (Sakura Finetek Europe 
B.V, Zoeterwoude, NL) and stored at -20ºC until use. Coronal sections of 10µm 
thickness were cut on a cryostat, dried, fixed in absolute alcohol for 10min at 4ºC and 
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processed for indirect immunohistochemistry. All incubations were carried out at 
room temperature. The sections were first pre-adsorbed with 10% normal rabbit 
serum for 30min and then incubated for 2h with rat monoclonal anti-mouse 
antibodies against the following antigens: mannose receptor (clone 5D3), CD68 
(clone FA11), CD11b (clone 5C6), CD204 (clone 2F8), CD3 (clone KT3) or MHC 
Class II (clone TIB120). After washing in 0.1M phosphate-buffered saline, sections 
were incubated with biotinylated rabbit anti-rat IgG secondary antibody for 30min, 
washed again and then incubated with avidin-biotin-peroxidase complex (Vectastain 
Elite ABC) for 30min. After another wash, the peroxidase was visualized using 
0.05% 3,3’-diaminobenzidine (DAB) as chromogen and 0.05% hydrogen peroxide as 
substrate. All the sections were counterstained with haematoxylin and dehydrated 
before mounting in DePeX (BDH Laboratory supplies, Poole, UK). Negative control 
sections were incubated in the absence of the primary antibody. Normal rabbit serum, 
biotinylated secondary antibody, and avidin-biotin-peroxidase complex were 
purchased from Vector Laboratories (Peterborough, UK). The antibodies from clones 
5D3, 2F8, 5C6 and TIB120 were kindly provided by Professor S Gordon (Sir 
William Dunn School of Pathology, Oxford, UK); FA11 and KT3 was purchased 
from Serotec Ltd (Kidlington, UK). The immunocytochemistry protocol for the anti-
MR antibody (5D3) was also investigated on brains fixed in 10% neutral buffered 
formalin, Bouin’s solution, 4% paraformaldehyde and periodate-lysine-
paraformaldehyde (PLP). Positive staining was achieved on formalin-fixed sections 
only if pepsin (pepsin 0.04% in 0.1M HCl, 10min) or microwave (3min in citrate 
buffer, cool for 5min, re-microwave 3min in citrate buffer) antigen retrieval steps 
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were included, the former giving the better results. No positive staining was seen in 
Bouins’ solution, 4% paraformaldehyde or PLP-fixed tissue. 
 For double immunofluorescence, brain sections were first blocked with 10% 
rabbit serum and then incubated overnight with mannose receptor antibody (1:50) 
followed by biotinylated rabbit anti-rat IgG for 45min and streptavidin-conjugated 
AF546 (Molecular Probes, Cambridge Bioscience, Cambridge, UK) for 30min. 
During the second round, sections were blocked with 10% goat serum, incubated with 
a rat monoclonal antibody against the γ1 chain of mouse laminin (Neomarkers, 
Freemont, CA, USA) (1:250) for 90min, followed by AF488-conjugated goat anti-rat 
IgG (Molecular Probes) for 30min. Sections were mounted in Mowiol (Harlow 
Chemical, Harlow, UK) and visualized with a LSM 510 Meta confocal laser scanning 
microscope (Carl Zeiss Ltd, Germany). Images were examined with the Zeiss LSM 5 
Image Examiner software. 
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 RESULTS 
 
Control animals 
Sections from the brains of three naïve C57BL/6J mice and from the intact 
contralateral optic nerves of mice with a right ONC were incubated with the anti-MR 
antibody. Three populations of macrophages were clearly stained: PVMs, meningeal 
macrophages (MMs) and choroid plexus macrophages (CPMs), reminiscent of ED2 
staining in the rat. PVMs were seen exclusively around vessels and located abluminal 
to endothelial cells and separate from the surrounding brain parenchyma (Figure 1). 
Double immunofluorescence showed MR-positive cells sandwiched between the γ1-
laminin-chain-positive endothelial and glial basement membranes (Figure 2). The 
cells had stout cell bodies and bore elongated flattened processes which both 
encircled and ran longitudinally along the vessels. They were particularly noticeable 
at bifurcations/trifurcations. Few cells in the white matter tracts such as the corpus 
callosum and the normal optic nerve were revealed by the anti-MR antibody (data not 
shown).  
Perivascular and meningeal macrophages, which were considered to express 
the MR in the above experiment, are known to be the only constitutively phagocytic 
cells in the normal CNS (Kida et al., 1993). Indeed this is in keeping with MR 
expression since one of the MR’s described functions is receptor-mediated 
endocytosis (Apostolopoulos and McKenzie, 2001). Moreover the MR-positive cells 
were located at sites (perivascular spaces and meninges) which are readily accessible 
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to intracerebroventricularly injected substances. This is reminiscent of ED2 positive 
macrophages in the rat brain, which have been shown to be selectively depleted after 
intracerebroventricular injection of clodronate-loaded liposomes (Polfliet et al., 
2001a). Liposomes are phagocytosed and intracellular accumulation of clodronate is 
toxic by forming a non-hydrolyzable analogue of ATP (Russell and Rogers, 1999) 
and triggering apoptosis (van Rooijen et al., 1996). We therefore injected clodronate-
loaded liposomes intracerebroventricularly in control mice to interrogate the function 
of MR-positive cells and verify their identity as PVMs. In these mice, no mannose 
receptor could be detected in perivascular spaces after immunocytochemistry with the 
5D3 monoclonal antibody (Figure 1). Sections of brains from naïve or PBS-
containing liposome injected mice revealed MR positivity during the same 
immunohistochemistry experiment. This showed that the MR expressing cells were 
constitutively phagocytic which confirms their identity as PVMs.  
Meningeal macrophages were also depleted (Figure 1) though not completely. 
This is in sharp contrast with the rat, where complete depletion of meningeal 
macrophages is achievable with 5-fold lower doses (on a per brain weight basis) of 
intracerebroventricular clodronate-loaded liposomes (Polfliet et al., 2001a). This 
might be due to a smaller subarachnoid space in the mouse and thus a more restricted 
flow of CSF over the brain surface, effecting liposomal delivery to the meninges. 
Alternatively it could mean that the mannose receptor is expressed by other cells in 
the meninges besides macrophages. 
Choroid plexus macrophages were the least affected by the 
intracerebroventricular injection, similar to the rat. This is because tight junctions are 
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expressed in the ependyma of the choroid plexus (Oldfield and McKinley, 1995). 
This impedes the access of intracerebroventricularly injected liposomes to choroid 
plexus macrophages. Indeed DiI-labelled liposomes also fail to access 
circumventricular organ tissue when injected intracerebroventricularly in the rat (data 
not shown). 
The immunocytochemistry protocol used in this study revealed the MR 
equally well in C57BL/6J and BALB/c mice.  
 
Acute inflammatory model 
To model an acute inflammatory injury without cell death, an intracerebral injection 
of 2µg of LPS was made into the right dorsal hippocampus of 3 mice (Andersson et 
al., 1992). The animals were sacrificed 24 hours later. At this time point, neutrophil 
margination to cerebral endothelium and microglial activation is observed in the brain 
(Andersson et al., 1992). The sections were stained with the anti-MR antibody. Only 
the PVMs were revealed by the antibody, in both the injected and uninjected 
hemispheres (Figure 3). While widespread upregulation of scavenger receptor, CD68, 
CR3 and MHC Class II on microglia was seen in this model (data not shown) in 
agreement with previous results (Bell et al., 1994), MR expression was confined to 
PVMs, MMs and CPMs; it was not upregulated on microglia or other cells. 
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Excitotoxic model 
Acute cerebral inflammation associated with neuronal death was modeled by 
intracerebral injection of the excitotoxin KA (1nM) in the right dorsal hippocampus. 
Mice were sacrificed 3 days later. Little or no neutrophil recruitment is usually 
observed in these pathological conditions whereas microglia are activated. 
(Andersson et al., 1991).  The MR antibody still selectively and exclusively labeled 
PVMs around the blood vessels (Figure 3), MMs and CPMs, with more PVMs in the 
ipsilateral side compared to the contralateral one. There was no detectable microglial 
expression of the MR, but microglia did express scavenger receptor, CD68, CR3, and 
MHC Class II (data not shown) in agreement with previous results (Andersson et al., 
1991; Bell et al., 1994).  
 
Chronic neurodegeneration model 
Bilateral injection of ME7 prion brain homogenate was performed in the mouse 
dorsal hippocampus. This induces chronic neurodegeneration accompanied by an 
atypical inflammation which contrasts with the acute inflammation accompanying the 
above-mentioned two models (Perry et al., 2002). Three animals were killed during 
the late stage of the disease, at 21 weeks. At this time point, marked microglial and 
astrocytic activation as well as T cell infiltration has been described (Betmouni et al., 
1996) and indeed upregulation of CR3 and CD68 was seen (Figure 4). Once again, 
MR expression was limited to PVMs (Figure 4), MMs and CPMs: it was upregulated 
on PVMs and they appeared to be more numerous. The strict perivascular distribution 
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of the MR was incompatible with expression by CD68-positive microglia or CD3-
positive T cells which were found in the parenchyma (Figure 4). 
 
Wallerian degeneration model 
The mouse right optic nerve was crushed intraorbitally. The animals were killed at 7 
and 28 days. It has been shown that microglia in the degenerating distal optic nerve 
segment are activated as evidenced by F4/80 glycoprotein and CD68 expression, with 
a maximum at day 7 (Lawson et al., 1994). This was confirmed in this study since 
CR3 and CD68 were upregulated. However the MR antibody still only revealed 
PVMs and MMs; the former were few in number (Figure 3). 
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DISCUSSION 
 
Our results are in agreement with a previous study showing restricted perivascular 
expression of the MR in the healthy adult CNS using immunocytochemistry and in 
situ hydridization (Linehan et al., 1999). The only other study of MR expression in 
the brain (Burudi and Regnier-Vigouroux, 2001) found a more diverse expression of 
the MR including astrocytes and neurons using immunocytochemistry. However this 
group used a different antibody (a rabbit polyclonal raised against a 22-mer from the 
cytoplasmic domain of MR) while 5D3, used in this study, is a mouse monoclonal 
antibody raised against a much larger fragment of the MR spanning carbohydrate 
recognition domains 4-7 (Zamze et al., 2002). The antibody 5D3 has been thoroughly 
characterized using immunocytochemistry, immunoprecipitation, Western blot, 
enzyme-liked immunosorbent assay and fluorescence-activated cell sorting 
(Martinez-Pomares et al., 2003; Zamze et al., 2002).  
We have set out to further explore the phagocytic capacity of MR-positive 
cells in the brain by injecting clodronate-loaded liposomes intracerebroventricularly – 
these are lethal to cells which ingest them. We show that MR-positive cells possess 
constitutive phagocytic potential since they are depleted. This also confirms their 
perivascular location since the intraventricularly injected liposomes could reach these 
cells. Their precise location within the perivascular space was established using 
confocal microscopy – they lie between the endothelial and glial basement 
membranes. This establishes the identity of the MR-positive cells as perivascular 
macrophages. 
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Our liposomes were mannosylated and one may argue that they would 
therefore target any cell which expresses mannose-binding molecules, including the 
MR. However it is quite clear that constitutive robust phagocytic ability is a 
prerequisite for ingestion of these multilamellar liposomes: they are large (size ranges 
from 0.2 to 3 µm), they have been shown to be only taken up by perivascular 
macrophages in the rat (Polfliet et al., 2001a), and the non-phagocytic ependymal 
epithelium, which expresses cerebellar soluble lectin (CSL), a mannose binding lectin 
(Kuchler et al., 1994), is not effected by this treatment (data not shown). 
 In the brain parenchyma it was noted that PVMs occur predominantly in grey 
matter: the corpus callosum had very few PVMs for instance. It is thus no surprise 
that no MR staining was observed in naïve optic nerve. The same has been noted with 
regard to ED2-positive PVMs in the rat (data not shown). This might be related to 
capillary density which is circa 4-fold higher in grey matter as opposed to white 
matter (Cavaglia et al., 2001).  
We have used a spectrum of models to study several types of brain 
inflammation: acute inflammation accompanying excitotoxicity (kainic acid) 
(Andersson et al., 1991), acute inflammation associated with the presence of 
endotoxin (lipopolysaccharide) (Andersson et al., 1992), chronic neurodegeneration 
(ME7 prion disease) (Betmouni et al., 1996) and chronic inflammation following 
Wallerian degeneration (optic nerve crush) (Lawson et al., 1994). These models are 
characterized by different cytokine profiles (Blond et al., 2002; Boche et al., 2003; 
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Cunningham et al., 2002; Palin et al., 2004) yet this was not reflected in the 
distribution of MR expression. In all models, MR expression was restricted to PVMs 
(as well as meningeal and choriod plexus macrophages), with no staining of either 
microglia or infiltrating haematogenous leucocytes in the parenchyma. Thus the 
identification of the MR as a PVM marker supports the notion that PVMs do not 
migrate into the parenchyma during inflammation, an issue which has been brought 
into question previously (Angelov et al., 1996). The possibility still remains that they 
migrate but lose MR expression. Also, the availability of such a marker in the mouse 
which retains its selectivity during brain pathology provides the opportunity to study 
this macrophage population in a species which is more amenable to genetic 
manipulation. 
The mannose receptor has various functions which are of interest with regard 
to its expression by PVMs. The first is the recognition of various microbial ligands 
(from Mycobacterium tuberculosis, Candida albicans, Pneumocystis carinii, 
Klebsiella pneumoniae, Streptococcus pneumoniae) resulting in their receptor-
mediated phagocytosis and enhanced microbicidal activity (Linehan et al., 2000a). 
Interestingly most of these pathogens are known to infect the CNS. Perivascular and 
meningeal macrophages, with the MR as a member of their broad armamentarium, 
are ideally situated to prevent infectious organisms from gaining access to the brain 
parenchyma. Indeed their depletion using liposomes resulted in a worsening of 
disease in a Streptococcus pneumoniae model of meningitis in the rat (Polfliet et al., 
2001b). 
 22 
 The second identified function of the MR is recognition and clearance of 
endogenous ligands, of which several have been identified (Linehan et al., 2000b). 
One of these is tissue plasminogen activator (tPA): the MR serves in its clearance by 
receptor-mediated endocytosis (Smedsrod et al., 1988). This function would be 
expected to be protective in acute inflammation accompanying excitotoxicity or focal 
ischaemia, since tPA is a key player in tissue destruction in this setting via activation 
of plasmin (Tsirka et al., 1997; Wang et al., 1998).  
The third role of the MR is adhesion. Binding between the MR on lymphatic 
endothelium and L-selectin on T cells was found to be important in the adherence of 
T cells to the endothelium (Irjala et al., 2001). The MR is not expressed on circulating 
rodent monocytes, so it must be expressed once the monocyte enters the perivascular 
space. It is tempting to suggest that it is important in tethering PVMs in the 
perivascular space. Interestingly brain microvessels display binding sites for the 
carbohydrate recognition domains 4-7 on the extracellular portion of the MR 
(Linehan et al., 2001). The MR knockout mouse should help in identifying any such 
role in adhesion (Lee et al., 2002). 
 A fourth hypothesized role of the MR is antigen transport. Ligand binding 
sites for the cysteine-rich domain of the MR have been detected in developing 
germinal centers in spleen and have been followed on dendritic-like cells migrating 
from the subcapsular area of lymph nodes into follicular areas (Martinez-Pomares et 
al., 1996). It has thus been suggested that the MR directs antigen (bound by the 
carbohydrate recognition domains) towards sites of developing clonal immune 
responses (by the cysteine-rich domain). It would be interesting to see whether such 
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migration is seen in cervical lymph nodes following brain inflammation. A fully 
functional soluble form of MR is generated by shedding of cellular MR by 
metalloprotease activiy (Martinez-Pomares et al., 1998) and a similar antigen 
transport potential has been suggested for soluble MR. Such a scenario is possible 
during CNS inflammation since interstitial fluid from the perivascular space is known 
to drain directly into nasal lymphatics and thus cervical lymph nodes through 
channels in the cribriform plate (Weller et al., 1996).  
CD163, a member of the scavenger receptor Type B superfamily, is a 
selective PVM marker in rat (Dijkstra et al., 1985) and human CNS (personal 
communication by Babs Fabriek). Several similarities in function between CD163 
and the MR are thus apparent. CD163 is similarly restricted to the perivascular 
macrophage in both normal and diseased brain parenchyma, plays a role in cell 
adhesion (Barbe et al., 1996; Wenzel et al., 1996) and is shed from the cell surface in 
a soluble form by metalloprotease activity (Hintz et al., 2002). 
In summary, we have shown that murine PVMs express the mannose receptor, 
which is involved in receptor-mediated phagocytosis, and that they are constitutively 
phagocytic. The mannose receptor is also expressed by MMs and CPMs, but not by 
microglia. Mannose receptor expression by macrophages located at blood-brain 
(perivascular), brain-CSF (meningeal) and CSF-blood (choroid plexus) interfaces 
supports a functional role of these cells in immunosurveillance of the brain’s external 
environment. We have further shown that mannose receptor expression remains 
restricted to these subsets of macrophages in various models of brain pathology. 
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LEGENDS 
 
Figure 1: Mannose receptor expression in naïve brain  
Representative brain sections from mice injected intracerebroventricularly with 
clodronate-loaded (C, D) or PBS-loaded liposomes (A, B), showing complete 
depletion of meningeal (C) and perivascular (D) macrophages. The sections were 
stained with the anti-mannose receptor antibody 5D3 and counterstained with 
haematoxylin. (A) and (C) show the meninges overlying the cortex; (B) and (D) show 
the cerebral parenchyma. Scale bar = 20µm 
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Figure 2: Localization of the PVM in the perivascular space by confocal microscopy. 
Confocal image from a naïve brain section double stained for the MR (red) and the 
γ1-laminin chain (green), which labels both glial and endothelial basement 
membranes. The image, 0.28µm in thickness, shows a vessel trifurcation with a PVM 
(red) characteristically located in the angle between two of the vessels (green) (A). 
The image was studied using the Zeiss LSM V Image Examiner software, which 
shows the PVM to be situated between the endothelial (*) and glial (ο) basement 
membranes (B-C). Image B is an orthogonal view of the PVM in image A, taken at 
the level of the green line. Images C-D are two other examples. Yellow colour 
represents areas of adhesion between the PVM and adjacent basement membrane. 
L=lumen. 
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Figure 3: Perivascular macrophages in different pathologies 
Representative brain sections at the level of the dorsal hippocampus from mice 
injected with LPS (A) and KA (B) and 7 days after optic nerve crush (C). They were 
stained with the anti-mannose receptor antibody 5D3 and counterstained with 
haematoxylin. MR expression remains restricted to the perivascular and meningeal 
compartments in these different pathologies. Scale bars A,B = 20µm; C = 40µm 
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Figure 4: Perivascular macrophages in chronic neurodegenerative disease 
Representative brain sections at the level of the dorsal hippocampus from mice 
injected with ME7 prion. They were stained with the anti-mannose receptor antibody 
5D3 (A, B), the anti-CD68 antibody FA11 (C) and the anti-CD3 antibody KT3 (D). 
The slides were counterstained with haematoxylin. MR expression has a strict 
perivascular distribution (A,B) incompatible with expression by microglia (C) and T 
cells (D) which are situated in the parenchyma proper. Scale bars: A, C, D = 20 µm; 
B = 100 µm 
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